MBIO (Mustang Bio) Tariff Resilience Score: 6/10 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBIO Mustang Bio Inc MBIO
30 GF Score
Price $0.64
! 2 Warning Signs
View Full Analysis

What is Mustang Bio Tariff Resilience Score?

Mustang Bio MBIO -2.53% 30 Tariff Resilience Score is 6 as of Jul. 18, 2026. GuruFocus rates MBIO with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,370 Biotechnology companies, Mustang Bio ranks better than 75.99% on this metric.

Mustang Bio has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Mustang Bio has Biotech firm with some reliance on international suppliers for research materials. Moderate exposure to tariffs, but potential to mitigate through alternative suppliers and domestic sourcing.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Mustang Bio might have Average Resilient.

Mustang Bio  (NAS:MBIO) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Mustang Bio Tariff Resilience Score Related Terms

MBIO vs ELAB, DRMA, PCSA: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Mustang Bio's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mustang Bio Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mustang Bio's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Mustang Bio's Tariff Resilience Score falls into.


MBIO
30GF Score
Mustang Bio Inc MBIO
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Mustang Bio (MBIO) has a Tariff Resilience Score of 6 as of Jul. 18, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Mustang Bio ranks #329 out of 1370 companies in the Biotechnology industry, placing it in the top 24%.
Is Mustang Bio's Tariff Resilience Score too high?
Mustang Bio's current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Mustang Bio's value of 6 is 50% above this industry median. Based on the distribution chart, Mustang Bio ranks #329 out of 1370 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Mustang Bio has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Mustang Bio's Tariff Resilience Score compare to ELAB and DRMA?
According to the Biotechnology industry distribution chart, Mustang Bio ranks #329 out of 1370 companies for Tariff Resilience Score. This places Mustang Bio in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Mustang Bio's value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,370 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mustang Bio's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mustang Bio's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mustang Bio stock overvalued right now?
Mustang Bio (MBIO) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Mustang Bio's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Mustang Bio (MBIO), the current Tariff Resilience Score is 6 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mustang Bio Business Description

Address 95 Sawyer Road, Suite 110, Waltham, MA, USA, 02453
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
30GF Score

Get the complete analysis for MBIO

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price